CoLucid Pharmaceuticals' IPO

CoLucid Pharmaceuticals raised a round of funding on May 06, 2015. Investors include Public.

CoLucid Pharmaceuticals (NASDAQ: CLCD) aims to advance drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company's pipeline includes lasmiditan, a trea…

Articles about CoLucid Pharmaceuticals' IPO: